Other studies indicated that the percentage of CD44+/CD24- cells is increased in lymph node metastases in invasive ductal carcinoma and that there is a high correlation between the presence of cells expressing CSC markers and metastases in regional lymph nodes [78, 79]. Here, CD44 is linked to invasive ductal breast carcinoma.